Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer

Abstract

ANXA1 can enhance the function of Treg cells and reduce the survival rate of patients with breast cancer. Targeting ANXA1 can reduce Treg cell function and shrink breast tumors.